Masupirdine

Masupirdine · Suven Life Sciences Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Masupirdine, covering 2026-01-12 to 2026-01-12. Get the full timeline:

Most recent: Clinical Trial Update: Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type [Phase 3]